| Description |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Roche Pharma |
Atezolizumab 1200mg/20ml |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Helix pharma |
Methotrexate 50mg/2ml
|
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Searle Pharma |
|
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Getz Pharma |
Trastuzumab 440mg/10ml |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Roche Pharma |
|
| Product Type |
Product Size |
| Tablets |
30'S |
| Product Company |
| Beacon Pharmaceuticals |
Sorafenib 200mg |
| Content | "
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma. | Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
| Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | "
Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis | Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent.
|
Reviews
There are no reviews yet.